Pregled bibliografske jedinice broj: 1224644
In vitro effects of ascorbic acid on viability and metabolism of patients’ osteosarcoma stem cells
In vitro effects of ascorbic acid on viability and metabolism of patients’ osteosarcoma stem cells // Acta pharmaceutica, 72 (2022), 4; 599-613 doi:10.2478/acph-2022-0040 (recenziran, kratko priopcenje, znanstveni)
CROSBI ID: 1224644 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
In vitro effects of ascorbic acid on viability and
metabolism of patients’ osteosarcoma stem cells
Autori
Jovičić, Marijana Šimić ; Pušić, Maja ; Antunović, Maja ; Ledinski, Maja ; Librenjak, Lucija ; Kolundžić, Robert ; Ribičić, Tomislav ; Trkulja, Vladimir ; Urlić, Inga
Izvornik
Acta pharmaceutica (1330-0075) 72
(2022), 4;
599-613
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, kratko priopcenje, znanstveni
Ključne riječi
osteosarcoma ; cancer stem cells ; tumor cell metabolism ; ascorbic acid
Sažetak
Stagnation in novelties of osteosarcoma (OS) treatment indicates the need for new therapeutic methods. OS cancer stem cells (OS-CSC) are taught to have the ability to self-renew and develop mechanisms of anticancer drug resistance, and this is why it is difficult to eradicate them. Their metabolism has been recognized as a potential target of therapeutic action. Ascorbic acid (AA) is considered to act pro- oxidative against OS-CSC in vitro by oxidative effect and by inhibition of glycolysis. This study examined an in vitro impact of AA on OS-CSC metabolism isolated from patients’ biopsies, with the aim of better understanding of OS-CSC metabolism and the action of AA on OS-CSC. OS-CSC were isolated using a sphere culture system and identified as stem cells using Hoechst 33342 exclusion assay. Determination of the dominant type of metabolism of OS-CSC, parental OS cells, human mesenchymal stem cells (hMSC) and U2OS OS lineage before and after AA treatment was done by Seahorse XF (Agilent). Cytotoxicity of high-dose AA was confirmed by the MTT test and was proven for all the examined cell types as well as HEK293. Seahorse technology showed that OS-CSC can potentially use both glycolysis and oxidative phosphorylation (OXPHOS), and can turn to glycolysis and slow metabolic potential in unfavorable conditions such as incubation in AA.
Izvorni jezik
Engleski
Znanstvena područja
Biologija, Interdisciplinarne prirodne znanosti
POVEZANOST RADA
Projekti:
HRZZ-IP-2018-01-7590 - Selektivno ciljanje matičnih stanica sarkoma askorbinskom kiselinom (ASTar) (Urlić, Inga, HRZZ - 2018-01) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb,
Prirodoslovno-matematički fakultet, Zagreb,
Klinika za traumatologiju,
Klinika za dječje bolesti
Profili:
Inga Urlić
(autor)
Maja Ledinski
(autor)
Maja Antunović
(autor)
Robert Kolundžić
(autor)
Marijana Šimić Jovičić
(autor)
Maja Pušić
(autor)
Vladimir Trkulja
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE